Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

ABA Chemicals investing in a tetraniliprole and triflumezopyrim project in Hubei Province, Chinaqrcode

May. 15, 2020

Favorites Print
May. 15, 2020
On May 7, journalist learned from Xiangyang Xiangcheng District Investment Promotion Center, China’s Hubei Province, that a pharmaceutical intermediates project invested in by Shanghai ABA Chemicals for Yuan500 million, is being set up in Xiangcheng. 
Phase one of the amide intermediates project in Xiangcheng covers newly built workshops and supporting facilities for the production of tetraniliprole, triflumezopyrim and etc. After the completion of the project, the annual production value is expected to reach Yuan500 million, with an annual tax contribution of Yuan25 million.
The project, launched by ABA Chemicals this time and chosen to be set up in Xiangcheng, is a complete recognition of Xiangcheng's pharma-chemical industrial strength. The project is expected to further promote the transformation and upgrading of Xiangcheng's pharma-chemical industry through the joint efforts of all the relevant parties. 
Source: AgroNews


More from AgroNewsChange

Hot Topic More

I wanna post a press Comment


Subscribe Email: *
Mobile Number:  





Subscribe China Special Biweekly to send news related to your mailbox